For most of my career, healthcare communication has worked the same way: one message, written for an average patient who doesn't actually exist, sent to everyone. A 70-year-old managing diabetes and a 30-year-old just diagnosed with the same condition would get the identical leaflet, the identical reminder call, the identical app notification. It wasn't anyone's fault — that was simply what mass communication could do. AI is the first real technology to change that math, and it's changing it faster than most of us expected.
What "personalized" actually means now
Personalization used to mean putting someone's first name in an email. Today it means an AI system pulling together a patient's medical history, their medication response, how they've engaged with past messages, and even the time of day they're most likely to open an app, and then deciding what to say, how to say it, and when — for that one person. One controlled study on AI-driven healthcare messaging found personalized messages nearly doubled response rates compared to standard communication (82.5 per cent versus 55.3 per cent), lifted medication adherence from 67.8 per cent to 89.4 per cent, and cut hospital readmissions nearly in half, from 21.4 per cent to 12.3 per cent (study on personalized healthcare messaging). That's not a marginal improvement — that's the difference between a patient who takes their medicine and one who doesn't. It's also why analysts expect the hyperpersonalization market in pharma and healthcare to more than double from roughly $21.8 billion in 2024 to nearly $50 billion by 2029 (Wipro).
From treating everyone the same to treating everyone as themselves
The bigger shift underneath this is philosophical, not just technical. Healthcare communication is finally moving from "what does this condition need" to "what does this person need." Stanford Health Care is a good example of what that looks like in practice: instead of one generic reminder for every patient due for a screening, it uses AI to combine clinical data with behavioral signals and build a different content journey for each patient group, which the health system credits with a 36% rise in preventive-screening appointments and a 28% drop in patient acquisition cost (case study on AI-driven patient segmentation). The point isn't the specific percentage — it's that the same health system, with the same budget, reached more of the right patients simply by no longer treating them as one group.
We've built our own smaller version of this belief into OneAlphaMed AI. Arogya, our medication-adherence app for elderly patients, doesn't send one reminder — it escalates differently for each patient, first to the patient, then to a family caregiver, based on their own missed-dose pattern, in a way a static SMS blast never could. And MedLink AI, our WhatsApp-based patient assistant, was built on the same idea: the way a newly diagnosed patient wants to be spoken to is not the way someone managing a condition for ten years wants to be spoken to, even if it's the same diagnosis.
Why this matters even more in India
This shift matters more, not less, in a market like ours. A generic English-language reminder means very little to a patient in a Tier-3 town who thinks and worries about their health in Hindi, Tamil, or Telugu. AI-driven voice and messaging systems built for Indian healthcare are already showing what's possible at scale — one platform reports cutting missed appointments by 60 per cent and hospital readmissions by 40 per cent simply by making preventive care and follow-up calls happen in a patient's own regional language, automatically, at population scale (Verbalyze). Personalization in a market like India isn't a luxury feature. It's often the only way the message actually lands at all.
The part we have to be honest about
None of this means AI personalization is automatically good, and I think the industry does patients a disservice when it pretends otherwise. A recent U.S. patient survey found that while 75 per cent of people have already interacted with AI in healthcare, only 13 per cent feel genuinely comfortable with it, and 51 per cent said AI actually makes them trust the healthcare system less — not more (CHAI patient survey). Interestingly, the same survey found trust jumps sharply — by over 80 per cent — when clear human accountability is built into the system. Patients don't distrust AI itself; they distrust AI making decisions about them with nobody answerable for it.
There's a real bias risk hiding inside "personalized" too. AI systems learn from whatever data they're trained on, and if that data underrepresents certain patients — by geography, income, or access to care — the system can end up serving those patients worse, not better, all while looking perfectly personalized to everyone else (health equity and AI bias). The World Health Organization has been direct about this: AI in health needs transparency, human accountability, and equity built in from the start, not bolted on afterward (WHO).
And then there's the strangest finding in all of this research: when cancer patients were shown chatbot responses and physician responses to the same medical questions, side by side, they rated the AI responses as more empathetic than the doctor's — consistently, and by a wide margin (Nature Digital Medicine). I don't read that as "AI is more caring than doctors." I read it as a warning: a fluent, well-worded AI response can feel more reassuring than it deserves to, especially to a worried patient, which is exactly why every AI-generated patient message needs to be grounded in approved medical evidence and reviewed, not left to write itself. That's the entire design principle behind Merlin AI, our own generative AI platform — it only answers from a client's approved evidence and label information, deployed inside their own environment, precisely so that "personalized" never quietly becomes "confidently wrong."
Where I think this actually goes
The honest version of this story isn't "AI will make healthcare communication personal." It's already doing that. The real question is whether we build it in a way patients can trust — grounded in real evidence, reviewed by real clinicians, with a real person accountable at the other end. The technology to speak to every patient as an individual, in their own language, at the right moment, already exists. What decides whether that becomes progress or noise is whether we're honest enough to keep a human in the loop.
